MedTrace Logo

Lactacyd Radiance (Lactic Acid) Prophetic Patch Test

NCT00679562 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2009-02-06

No results posted yet for this study

Summary

Primay objective:

To evaluate the potential of the products in eliciting adverse skin reaction.

Conditions

  • Hygiene

Interventions

DRUG

Lactic Acid

Application of occlusive patches containing test product. For 24 hours and repeat 2 weeks later for participants with no reaction to Lactacyd Radiance

OTHER

Distilled water

Application of patches containing distilled water for 24 hours

Sponsors & Collaborators

Principal Investigators

  • Taweeporn NATESUMROENG · Sanofi

Study Design

Allocation
NON_RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-03-31
Primary Completion
2008-04-30

Countries

  • Thailand

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00679562 on ClinicalTrials.gov